Angus C. Russell, Director at TherapeuticsMD, Inc. (TXMD), bought 35,000 shares at $6.15 ($215K) on 2015-05-12, disclosed to the SEC on 2015-05-13.
Open-market purchase of $215k TXMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| MNKKQ | SELL | 2020-11-16 | $7K | — | Filing → |
| TXMD | BUY | 2019-08-26 | $28K | — | Filing → |
| TXMD | BUY | 2019-08-15 | $99K | — | Filing → |